The zodiak trial: protocol of a double-blind, placebo-controled, two-year clinical trial of zoledronic acid as a disease-modifying drug in knee osteoarthritis with bone marrow lesions

The zodiak trial: protocol of a double-blind, placebo-controled, two-year clinical trial of zoledronic acid as a disease-modifying drug in knee osteoarthritis with bone marrow lesions

Saved in:
Bibliographic Details
Published in:Osteoarthritis and cartilage Vol. 27; p. S501
Main Authors: van Spil, W.E., Gielis, W.P., Weijnans, H.H., Custers, R.J., Bekkers, J.E., Schrijvers-Te Brake, K.A., Lafeber, F.P.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-04-2019
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1063-4584
1522-9653
DOI:10.1016/j.joca.2019.02.563